Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer
Open Access
- 28 January 2003
- journal article
- case report
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (1) , 25-30
- https://doi.org/10.1038/sj.bjc.6600687
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Cancer in patients on dialysis for end-stage renal disease: an international collaborative studyPublished by Elsevier ,1999
- [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].1986
- VP-16 and cisplatin as first-line therapy for small-cell lung cancer.Journal of Clinical Oncology, 1985
- PHARMACOKINETIC EVALUATION OF INCREASING DOSAGES OF ETOPOSIDE IN A CHRONIC-HEMODIALYSIS PATIENT1985
- Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).1979
- Kinetics of cis‐dichlorodiammineplatinumClinical Pharmacology & Therapeutics, 1979
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Analysis of platinum in biological materials by flameless atomic absorption spectrophotometryBiochemical Medicine, 1977